Publication:
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: Report of two cases and literature review

dc.contributor.authorMayuree Jirapinyoen_US
dc.contributor.authorJittima Manonaien_US
dc.contributor.authorYongyoth Herabutyaen_US
dc.contributor.authorSuporn Chuncharuneeen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-24T02:06:10Z
dc.date.available2018-08-24T02:06:10Z
dc.date.issued2007-05-01en_US
dc.description.abstractBackground: Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies. Objective: Using recombinant activated factor VII in primary postpartum hemorrhage. Material and Method: Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed. Results: The intractable hemorrhage stopped after treatment with recombinant activated factor VII Conclusion: The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.90, No.5 (2007), 977-981en_US
dc.identifier.issn01252208en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-34249009875en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/24884
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34249009875&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEffectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: Report of two cases and literature reviewen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34249009875&origin=inwarden_US

Files

Collections